Health Care Cost Savings from the Targeted Use of Dietary Supplements 2022–2030
Investing in wellness through supplementation can save billions in disease prevention. The CRN Foundation has commissioned Frost & Sullivan for an analysis of the potential health care cost savings that could be realized if specific at-risk populations were to use certain dietary supplements that have been shown to lower disease event risk. In addition, the report examines evidence demonstrating the use of specific dietary supplement ingredients can reduce direct and indirect medical costs.
Download full report (PDF) or access individual chapters.
- Background & Introduction | Excerpt (PDF)
- Omega-3 Fatty Acids and Coronary Artery Disease | Excerpt (PDF)
- Magnesium and Coronary Artery Disease | Excerpt (PDF)
- Soluble Fiber and Coronary Artery Disease | Excerpt (PDF)
- Vitamin K2 and Coronary Artery Disease | Excerpt (PDF)
- Calcium & Vitamin D and Osteoporosis | Excerpt (PDF)
- Lutein & Zeaxanthin and Age-related Macular Degeneration | Excerpt (PDF)
- B Vitamins and Cognitive Decline | Excerpt (PDF)
- Probiotics, Irritable Bowel Syndrome and Productivity | Excerpt (PDF)
- Choline and Early Childhood Cognitive Development | Excerpt (PDF)
- References (PDF)
- Infographic chart shown below (PDF)